Does ADALIMUMAB Cause Glomerulonephritis rapidly progressive? 36 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Glomerulonephritis rapidly progressive have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
36
Reports of Glomerulonephritis rapidly progressive with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
1
Deaths
25
Hospitalizations
How Dangerous Is Glomerulonephritis rapidly progressive From ADALIMUMAB?
Of the 36 reports, 1 (2.8%) resulted in death, 25 (69.4%) required hospitalization, and 2 (5.6%) were considered life-threatening.
Is Glomerulonephritis rapidly progressive Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Glomerulonephritis rapidly progressive?
HYDRALAZINE (292)
PREDNISONE (47)
TACROLIMUS (47)
METHOTREXATE (43)
MYCOPHENOLATE MOFETIL (43)
RITUXIMAB (40)
PEMBROLIZUMAB (33)
CYCLOPHOSPHAMIDE (31)
NIVOLUMAB (27)
ETANERCEPT (24)
Which ADALIMUMAB Alternatives Have Lower Glomerulonephritis rapidly progressive Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB